BRYNOVIN
Live / Registered — Registered (as of 16 Sept 2025)
What this means for you
Registered since 16 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98008966
- Registration number
- 7950846
- Mark type
- Stylized text
- Filed
- 23 May 2023
- Published for opposition
- 19 Mar 2024
- Registered
- 16 Sept 2025
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes
Owner
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
Prosecution history
- 16 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 26 Aug 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Aug 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Aug 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Jul 2025 — USE AMENDMENT FILED
- 31 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 18 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Mar 2025 — SOU EXTENSION 2 GRANTED
- 18 Mar 2025 — SOU EXTENSION 2 FILED
- 18 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2024 — SOU EXTENSION 1 GRANTED
- 28 May 2024 — SOU EXTENSION 1 FILED
- 07 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL